REVIEW
|
doi:10.20944/preprints202209.0296.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
non-small-cell lung cancer; performance status; cytotoxic chemotherapy; immune checkpoint inhibitor; cancer cachexia
Online: 20 September 2022 (05:53:12 CEST)